Amir Nashat, Director at FATE THERAPEUTICS INC (FATE), sold 137,546 shares at $13.78 ($1.9M) on 2019-01-28, disclosed to the SEC on 2019-01-30.
Open-market sale of $1.9M FATE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.78 | 463 | $6K | 0.3% |
| 2 | $13.78 | 675 | $9K | 0.5% |
| 3 | $13.78 | 1,316 | $18K | 1.0% |
| 4 | $13.78 | 67,546 | $931K | 49.1% |
| 5 | $13.78 | 67,546 | $931K | 49.1% |
| Total | $13.78 avg | 137,546 |
| $1.9M |
| 100% |
| Filing → |
| SRRK | BUY | 2022-06-24 | $6.2M | — | Filing → |
| MORF | SELL | 2021-05-25 | $20.4M | — | Filing → |
| MTCR | BUY | 2020-09-22 | $3.0M | — | Filing → |